30

Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

Embed Size (px)

Citation preview

Page 1: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage
Page 2: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

Meaningful Use:

Stage 2 Changes

Page 3: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage 3 proposed rule

• Changed the reporting period in 2015 (for everyone) and 2016 (for new participants)

• Changed thresholds to patient engagement measures• Reduced the number of meaningful use objectives to improve advanced

use of EHRs• Removed redundant measures and those that have become widely

adopted (aka “topped out”)

Changes

Page 4: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• All Eligible Providers would attest for 90 days in 2015– Any 90 day period in 2015

• Only new EP’s report for 90 days in 2016

Back to 90 Days in 2015

Page 5: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• The new rule states that starting in 2015, all providers (regardless of what stage they are currently in) must attest to certain objectives and measures found in Stage 2.

• If a provider is scheduled to be in Stage 1, they will participate in a modified version of Stage 2 that will allow for special exclusions to the measures found only in Stage 2 and not in Stage 1.

A Single Set of Objectives Regardless of Stage

Page 6: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

A Single Set of Objectives Regardless of Stage

Page 7: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• In order to simplify Stage 1 and Stage 2, CMS identified measures to remove from the program because they are “redundant,” “duplicative,” or “topped out.”– Record Demographics– Record Vital Signs– Record Smoking Status– Clinical Summaries– Structured Lab Results– Patient List– Patient Reminders– Summary of Care

• Measure 1 – Any Method• Measure 3 – Test

– Electronic Notes– Imaging Results– Family Health History

Measures Sent into Retirement

Page 8: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• Changed the threshold from the Stage 2 Objective for Patient Electronic Access measure number 2 from “5 percent” to “equal to or greater than 1.” – In other words, only one patient must view, download, or transmit his/her health

information.

• Changed the threshold from the Stage 2 Objective Secure Electronic Messaging from a percentage-based measure to a yes-no measure stating the “functionality fully enabled.”

• Consolidated all public health reporting objectives into one objective with measure options following the structure of the Stage 3 Public Health Reporting Objective.

Changes to Existing Measures

Page 9: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• Stage 1 and Stage 2 have always required both core objectives and menu objectives.

• CMS decided to eliminate all menu objectives and offer a shorter list of “core” objectives instead.

• For providers scheduled to be in Stage 1, this means that three current menu objectives would now be required:– Perform Medication Reconciliation– Patient Specific Educational Resources– Public Health Reporting Objectives (multiple options)

Farewell Menu Set

Page 10: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• With the removal of measures and consolidation of Stage 1 and Stage 2, all providers in 2015-2017 will be required to successfully meet a total of 9objectives plus 1 public health reporting objective. (NOTE: Stage 1 providers can use new exclusions for measures only found in Stage 2.)

Farewell Menu Set

Page 11: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• Protect Electronic Health Information – Measure: Perform a security risk analysis.

• No Alternate Exclusions and/or Specifications

• Clinical Decision Support – Must satisfy both Measures– Measure 1: Implement five clinical decision support interventions

related to four or more clinical quality measures at a relevant point in patient care for the entire EHR reporting period.

The Core Objectives

Page 12: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• Measure 2: The EP has enabled and implemented the functionality for drug-drug and drug allergy interaction checks for the entire EHR reporting period– Exclusions: For an EHR reporting period in 2015 only, an EP who is scheduled to

participate in Stage 1 in 2015 may satisfy the following in place of measure 1: (Measure #2 is still mandatory)

– Alternate Exclusion: Implement one clinical decision support rule relevant to specialty or high clinical priority along with the ability to track compliance with that rule.

The Core Objectives

Page 13: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• Computerized Provider Order Entry (CPOE) – Measure 1: More than 60 percent of medication orders created by the

EP during the EHR reporting period are recorded using computerized provider order entry. • Exclusion: Any EP who writes fewer than 100 medication orders

during the EHR reporting period – Measure 2: More than 30 percent of laboratory orders created by the

EP during the EHR reporting period are recorded using computerized provider order entry. • Exclusion: Any EP who writes fewer than 100 laboratory orders

during the EHR reporting period.

The Core Objectives

Page 14: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• Measure 3: More than 30 percent of radiology orders created by the EP during the EHR reporting period are recorded using computerized provider order entry. – Exclusion: Any EP who writes fewer than 100 radiology orders during

the EHR reporting period • Alternate Measure 1: For Stage 1 providers in 2015, more than 30 percent

of all unique patients with at least one medication in their medication list seen by the EP during the EHR reporting period have at least one medication order entered using CPOE; or more than 30 percent of medication orders created by the EP during the EHR reporting period are recorded using computerized provider order entry.

The Core Objectives

Page 15: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• Alternate Exclusion for Measure 2: Providers scheduled to be in Stage 1 in 2015 may claim an exclusion for measure 2 (laboratory orders) of the Stage 2 CPOE objective for an EHR reporting period in 2015.

• Alternate Exclusion for Measure 3: Providers scheduled to be in Stage 1 in 2015 may claim an exclusion for measure 3 (radiology orders) of the Stage

2 CPOE objective for an EHR reporting period in 2015.

The Core Objectives

Page 16: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• E-Prescribing (eRx) – Measure 1: More than 50 percent of all permissible prescriptions, or all prescriptions,

written by the EP are queried for a drug formulary and transmitted electronically using Certified EHR Technology.

– Exclusions: Any EP who - • Writes fewer than 100 permissible prescriptions during the EHR reporting period;

or • Does not have a pharmacy within his or her organization and there are no

pharmacies that accept electronic prescriptions within 10 miles of the EP's practice location at the start of his or her EHR reporting period.

– Alternate EP Measure: For Stage 1 providers in 2015, more than 40 percent of all permissible prescriptions written by the EP are transmitted electronically using CEHRT.

The Core Objectives

Page 17: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• Health Information Exchange– Measure: The EP that transitions or refers their patient to another setting

of care or provider of care that (1) uses CEHRT to create a summary of care record, and (2) electronically transmits such summary to a receiving provider for more than 10 percent of transitions of care and referrals.• Exclusion: Any EP who transfers a patient to another setting or refers a

patient to another provider less than 100 times during the EHR reporting period.

• Alternate Exclusion: Provider may claim an exclusion for the Stage 2 measure that requires the electronic transmission of a summary of care document if for an EHR reporting period in 2015, they were scheduled to demonstrate Stage 1, which does not have an equivalent measure.

The Core Objectives

Page 18: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• Patient Education – Measure 1: Patient-specific education resources identified by Certified

EHR Technology are provided to patients for more than 10 percent of all unique patients with office visits seen by the EP during the EHR reporting period.• Exclusion: Any EP who has no office visits during the EHR reporting period. • Alternate Exclusion: Provider may claim an exclusion for the measure of the Stage 2

Patient Specific Education objective if for an EHR reporting period in 2015 they were scheduled to demonstrate Stage 1 but did not intend to select the Stage 1 Patient Specific Education menu objective.

The Core Objectives

Page 19: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• Medication Reconciliation – Measure 1: The EP performs medication reconciliation for more than

50 percent of transitions of care in which the patient is transitioned into the care of the EP.• Exclusion: Any EP who was not the recipient of any transitions of care

during the EHR reporting period. • Alternate Exclusion: Provider may claim an exclusion for the measure of

the Stage 2 Medication Reconciliation objective if for an EHR reporting period in 2015 they were scheduled to demonstrate Stage 1 but did not intend to select the Stage 1 Medication Reconciliation menu objective.

The Core Objectives

Page 20: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• Patient Electronic Access – Measure 1: More than 50 percent of all unique patients seen by the EP during

the EHR reporting period are provided timely (within 4 business days after the information is available to the EP) online access to their health information.

– Measure 2: At least one patient seen by the EP during the EHR reporting period (or their authorized representatives) views, downloads, or transmits his or her health information to a third party.

– Exclusions: Any EP who: • Neither orders nor creates any of the information listed for inclusion as part of the

measures; or

The Core Objectives

Page 21: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

– Conducts 50 percent or more of his or her patient encounters in a county that does not have 50 percent or more of its housing units with 4Mbps broadband availability according to the latest information available from the FCC on the first day of the EHR reporting period.

– Alternate Exclusion: Providers may claim an exclusion for the second measure if for an EHR reporting period in 2015 they were scheduled to demonstrate Stage 1, which does not have an equivalent measure.

The Core Objectives

Page 22: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• Secure Electronic Messaging – Measure 1: During the EHR reporting period, the capability for patients to

send and receive a secure electronic message with the provider was fully enabled.• Exclusion: Any EP who has no office visits during the EHR reporting period, or any

EP who conducts 50 percent or more of his or her patient encounters in a county that does not have 50 percent or more of its housing units with 4Mbps broadband availability according to the latest information available from the FCC on the first day of the EHR reporting period.

• Alternate Exclusion: An EP may claim an exclusion for the measure if for an EHR reporting period in 2015 they were scheduled to demonstrate Stage 1, which does

not have an equivalent measure.

The Core Objectives

Page 23: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• In addition to reporting the objectives above, EPs must also report on either 1 or 2 public health reporting measures. – Providers scheduled to be in Stage 1 must choose 1 of the possible 5 measures.– Providers scheduled for Stage 2 must choose 2 of the possible 5 measures.

• Immunization Registry Reporting• Syndromic Surveillance Reporting• Case Reporting• Public Health Registry Reporting• Clinical Data Registry Reporting• NOTE: A measure from options 1-4 must be selected

Public Health Measure Options

Page 24: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• An EP scheduled to be in Stage 2 in 2015 must meet 2 measures. – Measure Option 1 – Immunization Registry Reporting: The EP is in active engagement

with a public health agency to submit immunization data. • Exclusions: Any EP meeting one or more of the following criteria may be excluded from the immunization

registry reporting measure if the EP– • Does not administer any immunizations to any of the populations for which data is collected by its jurisdiction's

immunization registry or immunization information system during the EHR reporting period; • Operates in a jurisdiction for which no immunization registry or immunization information system is capable of

accepting the specific standards required to meet the CEHRT definition at the start of the EHR reporting period; or

• Operates in a jurisdiction where no immunization registry or immunization information system has declared readiness to receive immunization data from the EP at the start of the EHR reporting period

– Measure Option 2 – Syndromic Surveillance Reporting: The EP is in active engagement with a public health agency to submit syndromic surveillance data.

Public Health Measure Options

Page 25: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

– Exclusion for EPs: Any EP meeting one or more of the following criteria may be excluded from the syndromic surveillance reporting measure if the EP:

– Is not in a category of providers from which ambulatory syndromic surveillance data is collected by their jurisdiction's syndromic surveillance system;

– Operates in a jurisdiction for which no public

Public Health Measure Options

Page 26: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• For an EHR reporting period in 2015, all Medicare providers must attest by February 29, 2016.

• Providers will not be able to attest to meaningful use for an EHR reporting period in 2015 prior to January 4, 2016.

Attestation

Page 27: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

• EPs must report nine of the MU Stage 2 CQMs in 2015, 2016, and 2017 – For 2015 through 2017, Medicare Eligible Professionals (EPs) can meet the clinical

quality measurement (CQM) reporting requirement for the EHR Incentive Program by satisfying nine of the 64 electronic clinical quality measures (eCQMs) in the Stage 2 Final Rule menu: First year Meaningful Use (MU) EPs must attest their selected CQMs.

– Returning EPs may attest or eReport their selected measures.

• EPs choosing to attest in 2015 must capture and report CQMs for a 90-day period within calendar year 2015.

Clinical Quality Measures

Page 28: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

Reporting period requirements vary by year/EP status • EPs choosing to attest in 2015 must capture and report CQMs for a 90-day period within calendar year 2015.

2016 & 2017 • Returning MU EPs choosing to attest in 2016 must collect and report data for the full calendar year. • First time MU EPs must report on a 90-day period within 2016.

Clinical Quality Measures

Page 29: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

eReport submissions must meet specific requirements:• Submissions must include the eCQM reporting program requirements for

both MU and the CMS Physician Quality Reporting System (PQRS) program in one submission.

• Starting in 2016, submissions must capture eCQM data for the full calendar year.

• Individual EPs will submit their selected CQMs through the PQRS Portal. • Groups will electronically report their selected CQMs through the PQRS

Portal either using: o Quality Reporting Document Architecture (QRDA), or

via the Group Practice Reporting Option (GPRO) Web Interface.

Clinical Quality Measures

Page 30: Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage

Dara J. Barrera | Manager, HIT and Practice ManagementHealth Care DeliveryMichigan State Medical [email protected] | www.msms.org